{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02321878","recordId":"NCT02321878","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02321878-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02321878.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02321878.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2014-12-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2014-12-17","publishedAt":"2026-08-23","recordId":"NCT02321878","recordSha256":"981c720a732c19c1fd4f8a811676ae0872792d911ec4e23ba5c8864d68b351d1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02321878?a=1&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Arms and Interventions","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2015-05-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2015-05-20","publishedAt":"2026-08-23","recordId":"NCT02321878","recordSha256":"a37084742098aa0aa1d1c70e105c39030f834548ae7fcf04094256e8aebf4fa9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02321878?a=2&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2015-06-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2015-06-05","publishedAt":"2026-08-23","recordId":"NCT02321878","recordSha256":"3a278fe80131eaceb63d54c0f42c35fb7147811b1e34f0eed37d4dc32ab14f90","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02321878?a=3&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2015-11-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2015-11-04","publishedAt":"2026-08-23","recordId":"NCT02321878","recordSha256":"7bf88b09eda5d803ecc58be9a5c60942278f00690347d979bf2b59eb2f1c8914","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02321878?a=4&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2016-03-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2016-03-02","publishedAt":"2026-08-23","recordId":"NCT02321878","recordSha256":"3dff2b0348708b3eeab9dcf8c73abfb11f7b8d4f8b07c9f26b9480dd4bebfe2b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02321878?a=5&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2017-02-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2017-02-17","publishedAt":"2026-08-23","recordId":"NCT02321878","recordSha256":"4ac465439ef9bfe4a240eb79eb4f614de0499b1b24f8d4d724375f8cc306bf37","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02321878?a=6&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2017-06-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"liraglutide","submittedDate":"2017-06-22","publishedAt":"2026-08-23","recordId":"NCT02321878","recordSha256":"96fdf2aafa32251a2bc44a14fccca8a0804271cdab443abac9ad376b3cc9d6df","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02321878?a=7&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2017-08-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-08-31","publishedAt":"2026-08-23","recordId":"NCT02321878","recordSha256":"10ea46dfb0622f35724c4ae71ee0e809556b0c2dbf8ff3f22da06ca084dbe09f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02321878?a=8&tab=history","studyType":"OBSERVATIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"c1e8b1cb8b80b56be25c153d622a4ab6624c8578767b3266bbe03d08001b7249"}}